DCM Shriram Fine Chemicals Limited has fulfilled its regulatory compliance obligations by submitting mandatory certificates to stock exchanges for the quarter ended March 31, 2026. The submission ensures adherence to SEBI (Depositories & Participants) Regulations, 2018, specifically Regulation 74(5).

Regulatory Submission Details

Company Secretary Kokila Arora communicated the certificate submission to both BSE and NSE on April 14, 2026. The certificates were received from KFIN Technologies Limited, which serves as the company's Registrar and Share Transfer Agent.

Certificate Confirmation

KFIN Technologies Limited issued certificates dated April 7, 2026, to both Central Depository Services (India) Limited (CDSL) and National Securities Depository Limited (NSDL). The certificates confirm that details of securities dematerialized and rematerialized during the quarter have been furnished to all stock exchanges where DCM Shriram Fine Chemicals Limited shares are listed.

S R Ramesh, Deputy Vice President at KFIN Technologies Limited, signed the certificates on behalf of the registrar. The certificates were addressed to the respective depositories and copied to DCM Shriram Fine Chemicals Limited's registered office in New Delhi.

Company Information

DCM Shriram Fine Chemicals Limited operates with its registered and corporate office located at 6th Floor, Kanchenjunga Building, 18, Barakhamba Road, New Delhi. The company maintains manufacturing facilities at Daurala, Meerut, including Daurala Organics and Daurala Chemicals units.

The regulatory submission demonstrates the company's commitment to maintaining transparency and compliance with SEBI regulations governing depositories and participants in the Indian securities market.

Aditi Dhar has completely divested her shareholding in DCM Shriram Fine Chemicals Ltd. through an off-market share sale to Tilak Dhar & Sons. The transaction represents a significant change in the promoter group's internal shareholding structure, with Dhar reducing her stake to zero.

Transaction Details

The divestment involved the complete sale of 255,452 equity shares to Tilak Dhar & Sons through an off-market transaction completed on March 30, 2026. The transaction was disclosed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Shareholding Pattern Changes

Prior to the transaction, Dhar held 255,452 shares representing 0.29% of DCM Shriram Fine Chemicals' equity capital. Following the complete divestment, her shareholding has been reduced to zero, with all shares transferred to Tilak Dhar & Sons within the promoter group structure.

Regulatory Compliance and Promoter Group Structure

The transaction maintains the overall promoter group shareholding at 50.11% of the company's total equity capital of 86,992,185 shares. The promoter group includes Alok Shriram Karta L. Bansi Dhar & Sons (HUF) with 13.83%, Mrs. Urvashi Tilakdhar & Family with 10.28%, and other family members maintaining their respective stakes.

The regulatory filing was signed by Tilak Dhar & Sons as the buyer, with the disclosure dated April 1, 2026, from New Delhi. DCM Shriram Fine Chemicals trades on both NSE and BSE exchanges, maintaining its listing status throughout the transaction.